Metastatic malignant melanoma – Life with Disease

Go back

Metastatic malignant melanoma occurs when this aggressive skin cancer spreads from its original site to other parts of the body, most commonly affecting the skin and tissue just below it, lungs, liver, bones, and brain. While this stage of melanoma presents serious challenges, recent years have brought remarkable advances in treatment options that are helping patients live longer and with better quality of life.

Understanding Prognosis in Metastatic Melanoma

The outlook for people with metastatic melanoma depends on several important factors, and understanding what affects survival can help patients and families prepare for the journey ahead. The location where the cancer has spread plays a significant role in determining how long someone might live and how they will respond to treatment. Research examining over 1,500 patients with stage IV melanoma found meaningful differences in survival based on where the cancer had traveled[7].

Patients whose melanoma spread to the skin under the surface, nearby lymph nodes, or the digestive tract had the best outlook, with a median survival (the point at which half the patients are still alive) of about 12 and a half months. Those with cancer only in the lungs had a median survival of roughly 8 months. Unfortunately, people whose melanoma reached the liver, brain, or bones faced the most difficult prognosis, with a median survival of approximately 4 months. Looking at longer-term survival, about 14% of patients in the first group were still alive five years later, compared to 4% in the lung-only group and 3% in the liver, brain, or bone group[7].

Another important factor affecting prognosis is the level of an enzyme called lactate dehydrogenase, or LDH, in the blood. Elevated LDH levels typically indicate more aggressive disease and are associated with shorter survival times. Despite these statistics, it’s crucial to remember that every person’s cancer behaves differently, and newer treatments developed in recent years have improved outcomes considerably beyond what older statistics suggest[7].

⚠️ Important
The ten-year survival rate for patients with metastatic melanoma is less than 10%, making this a very serious condition[7]. However, survival statistics are based on past data and may not reflect the benefits of newer treatment approaches. Each person’s situation is unique, and discussing your individual prognosis with your medical team will provide the most accurate picture.

If melanoma is diagnosed at an early stage, survival rates are excellent, approaching 94%[1]. However, when the disease spreads throughout the body, the challenges become much greater. According to recent estimates, from 2014 to 2018, metastatic melanoma occurred in about 0.9 per 100,000 people in the United States[1].

Natural Progression Without Treatment

When metastatic melanoma is left untreated, the disease typically continues to grow and spread throughout the body. The cancer’s tendency to move rapidly from one location to another is what makes melanoma particularly dangerous compared to other types of skin cancer. Melanoma is distinct because it spreads locally within the skin, regionally to nearby lymph nodes, and distantly to organs far from where it started[1].

The risk of metastasis is directly connected to certain characteristics of the original melanoma. When doctors examine the primary tumor, they look at how deeply it has invaded into the skin and whether it shows signs of ulceration, which means the surface layer of skin covering the tumor has broken down. Deeper tumors and those with ulceration are more likely to spread to other parts of the body[1].

The natural course of untreated metastatic melanoma involves the cancer growing larger at existing sites and potentially developing new tumors in additional locations. Melanoma cells have a remarkable ability to survive in different environments throughout the body, which is why they can establish themselves in such diverse organs. The process by which cancer spreads involves several steps: the cells must invade nearby tissue, enter blood vessels or lymph channels, travel through the body, exit these vessels, and then establish new colonies in distant organs[1].

As the disease progresses without treatment, symptoms typically become more noticeable and troublesome. The specific symptoms depend on where the cancer has spread, but generally include increasing fatigue, unintentional weight loss, and various symptoms related to the affected organs. The timeframe for progression varies considerably from person to person, but metastatic melanoma without treatment generally leads to declining health over months rather than years.

Possible Complications

Metastatic melanoma can lead to numerous complications as it affects different parts of the body. The symptoms and complications you might experience depend largely on where the cancer has traveled. Understanding these potential problems can help you recognize them early and seek appropriate care[2].

When melanoma spreads to the skin and the tissue directly beneath it, you may notice hardened lumps under your skin or swollen, painful lymph nodes. These lumps can sometimes be uncomfortable or interfere with movement if they develop near joints. The lymph nodes most commonly affected are those in the armpit or groin area, and swelling in these areas can be both visible and tender to touch[2].

If the cancer reaches the lungs, breathing problems become a primary concern. You might develop shortness of breath, even with minimal physical activity, or a persistent cough that doesn’t improve over time. Some people experience chest discomfort or feel like they cannot get enough air, which can be frightening and limit daily activities[2].

Melanoma that spreads to the liver can cause the liver to enlarge, creating a sensation of fullness or discomfort under the right side of your rib cage. Loss of appetite is common when the liver is affected, and some people develop nausea. The liver plays many crucial roles in the body, including filtering toxins and producing proteins needed for blood clotting, so its involvement can lead to additional complications[2].

When cancer reaches the bones, it can cause significant pain in the affected areas. In some cases, the cancer weakens bones enough that they break even without significant trauma, a condition called a pathological fracture. Bone involvement can seriously impact mobility and quality of life[2].

Brain metastases bring their own set of serious complications. Headaches that persist or worsen over time can be an early warning sign. Some people experience seizures, which are sudden episodes of abnormal electrical activity in the brain. You might also notice weakness or numbness in your arms or legs, changes in your ability to think clearly, or problems with balance and coordination. These neurological symptoms require immediate medical attention[2].

General complications that affect the whole body include profound fatigue and unintentional weight loss. Fatigue with metastatic melanoma goes beyond normal tiredness—it’s an overwhelming exhaustion that doesn’t improve with rest and can make even simple tasks feel impossible. Weight loss occurs even when you’re trying to maintain your weight, partly because cancer cells use a lot of the body’s energy and partly because treatment and the disease itself can reduce appetite[5].

Impact on Daily Life

Living with metastatic melanoma affects nearly every aspect of daily life, from physical abilities to emotional well-being, relationships, work, and leisure activities. The disease and its treatment demand significant adjustments, and finding ways to maintain quality of life becomes an important focus.

Physical limitations often develop as the disease progresses or during treatment. The profound fatigue that accompanies metastatic melanoma can make getting through a normal day feel like climbing a mountain. Activities that once seemed effortless—such as grocery shopping, preparing meals, or even showering—may require rest breaks. Many people find they need to prioritize their energy, choosing carefully which activities matter most and letting go of others. This reality can be frustrating, especially for those who were previously very active[13].

Treatment side effects add another layer of difficulty. Depending on which treatments you receive, you might experience nausea, changes in appetite, skin reactions, or other symptoms that interfere with normal routines. Some treatments cause hair loss, which, while not physically limiting, can affect how you feel about yourself and how comfortable you are in social situations. Other side effects like pain, shortness of breath, or digestive problems can restrict what you’re able to do[15].

The emotional and psychological impact of metastatic melanoma cannot be overstated. Fear, anxiety, sadness, and anger are all normal responses to facing a life-threatening illness. Many people experience waves of different emotions—feeling hopeful one day and discouraged the next. The uncertainty about the future can be particularly challenging. Will treatment work? How long will you live? These questions often create ongoing stress that affects sleep, concentration, and relationships[2].

Relationships with family and friends often change when someone has metastatic melanoma. While many loved ones want to help, they may not know what to say or do, leading to awkward interactions or avoidance. Some people report feeling isolated because friends don’t know how to act around them. On the other hand, facing a serious illness can also deepen relationships, bringing families closer together as they navigate challenges together[13].

Work life typically requires significant modifications. Depending on your symptoms and treatment schedule, you might need to reduce your hours, work from home, or stop working altogether. This change can be difficult both financially and emotionally, especially if your identity and social connections are tied to your career. Explaining your situation to employers and coworkers requires difficult conversations about your health and limitations.

Social activities and hobbies often need to be adjusted or temporarily set aside. If you enjoyed physical activities like hiking or sports, you may need to find gentler alternatives or accept that these pursuits are no longer possible. Planning social events becomes complicated because you can’t always predict how you’ll feel on any given day. Learning to say “no” without guilt becomes an important skill—understanding that protecting your health and energy is not selfish but necessary[14].

⚠️ Important
Taking care of yourself emotionally and physically is not a luxury—it’s essential when living with metastatic melanoma. Self-care might mean gentle yoga instead of intense exercise, taking naps when needed, or spending time doing activities you love. Remember that you are more than your diagnosis, and making time for things that bring you peace and joy remains important[14].

Financial concerns add another burden to daily life. Even with insurance, cancer treatment often comes with significant out-of-pocket costs. There may be expenses for travel to appointments, prescription medications, special equipment, or household help. Some people need to access their savings or apply for financial assistance programs to manage these costs[13].

Despite these challenges, many people with metastatic melanoma find ways to maintain meaning and purpose in their lives. Some focus on spending quality time with loved ones, pursuing creative interests, or finding ways to help others. Support groups, whether in-person or online, provide connection with others who truly understand what you’re going through. Counseling or therapy can help you process emotions and develop coping strategies[2].

Practical strategies for managing daily life include preparing for appointments by writing down questions beforehand, keeping a journal of symptoms to discuss with your doctor, using a calendar to track medication schedules and appointments, and accepting help when others offer it. Creating a team of trusted people—family, friends, healthcare providers—who can support you in different ways makes the burden lighter.

Support for Family Members

When someone is diagnosed with metastatic melanoma, the entire family is affected. Family members and close friends play a crucial role in supporting the patient, but they also need information, resources, and support for themselves. Understanding clinical trials and how to help a loved one navigate treatment decisions is particularly important.

Clinical trials offer access to new treatments that may not yet be widely available. For metastatic melanoma, participating in a clinical trial might mean trying a cutting-edge therapy that could be more effective than standard options. Given how rapidly melanoma treatments have advanced in recent years, clinical trials have become an important consideration for many patients. Family members should understand that clinical trials are voluntary, carefully designed research studies that test new treatments while protecting participants’ safety[6].

When considering clinical trials, families should know that participants typically receive close monitoring and expert care from specialized teams. The research staff explains the study in detail, including potential benefits and risks, before asking for consent. Patients can leave a clinical trial at any time if they choose to do so. For many people with stage IV melanoma, doctors strongly encourage considering clinical trials as a treatment option because they may provide access to the most advanced therapies available[6].

Family members can help by researching clinical trial options together with the patient. Many cancer centers maintain lists of available trials, and online databases allow you to search for studies based on specific criteria like cancer type, stage, and location. When you identify potentially suitable trials, help your loved one compile questions to ask the research team, such as what the trial involves, how often visits are required, what side effects might occur, and whether there are any costs to participants.

Beyond clinical trials, families can assist in numerous practical ways. Transportation to and from appointments often becomes necessary, especially when treatment causes fatigue or other side effects that make driving unsafe. Help with meals, housework, childcare, and errands relieves burden and allows the patient to focus on treatment and recovery. Simply being present—sitting with your loved one during infusions, attending doctor appointments to help remember information, or just spending time together—provides invaluable emotional support[13].

Understanding what your loved one is going through helps you provide better support. Learning about metastatic melanoma, treatment options, and expected side effects prepares you for what lies ahead. However, avoid overwhelming the patient with information or opinions unless they ask for it. Let them take the lead in making decisions about their care, while making it clear you’re available to help research options, discuss concerns, or simply listen.

Communication becomes especially important when someone has metastatic melanoma. Family members sometimes avoid talking about the illness because they fear saying the wrong thing or making the patient feel worse. However, most patients appreciate having loved ones they can talk to openly about their fears, hopes, and feelings. Ask your family member what kind of support they want. Some people prefer to focus on positive topics and maintain normalcy as much as possible, while others need to process their emotions by talking about their illness[13].

Financial coordination is another area where families can help. Navigating insurance claims, understanding bills, researching assistance programs, and managing medical expenses can overwhelm someone dealing with illness. A family member might take on the role of handling these practical matters, communicating with insurance companies, or researching charitable organizations that provide financial help to cancer patients[13].

Family members and caregivers must also take care of their own physical and emotional health. Caring for someone with metastatic melanoma is demanding and can lead to burnout if you don’t maintain your own well-being. Make time for activities you enjoy, maintain your own medical appointments, get adequate sleep, and seek support when you need it. Support groups specifically for caregivers provide a space to share experiences and learn coping strategies from others in similar situations. Remember that taking care of yourself isn’t selfish—it ensures you can continue providing the support your loved one needs[13].

As the disease progresses, families may need to have difficult conversations about preferences for end-of-life care, including where the patient would like to be cared for and what level of medical intervention they want. While these discussions are emotionally challenging, having them allows everyone to understand and respect the patient’s wishes. Hospice services can provide compassionate care and support for both patients and families during this time.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Nivolumab (Opdivo) – An immune checkpoint inhibitor that helps the immune system fight melanoma by blocking the PD-1 protein
  • Pembrolizumab (Keytruda) – A PD-1 inhibitor immunotherapy drug used to strengthen the immune system’s ability to attack cancer cells
  • Ipilimumab (Yervoy) – An immunotherapy drug that can be used alone or combined with nivolumab to enhance immune response against melanoma
  • Dabrafenib (Tafinlar) – A targeted therapy that blocks the BRAF protein in melanomas with BRAF gene mutations, typically combined with trametinib
  • Trametinib (Mekinist) – A MEK inhibitor used in combination with dabrafenib for targeted treatment of BRAF-mutated melanoma
  • Vemurafenib (Zelboraf) – A BRAF inhibitor for melanomas with BRAF V600 mutations, usually combined with cobimetinib
  • Cobimetinib (Cotellic) – A MEK inhibitor used alongside vemurafenib for targeted therapy of BRAF-mutated melanoma
  • Encorafenib (Braftovi) – A BRAF inhibitor combined with binimetinib for treating melanoma with BRAF mutations
  • Binimetinib (Mektovi) – A MEK inhibitor used with encorafenib as combination targeted therapy
  • Aldesleukin (Proleukin, interleukin-2) – An immunotherapy drug approved for metastatic melanoma, can be given systemically or directly into tumors
  • Dacarbazine – A chemotherapy drug that was the standard treatment for many years, though newer therapies have largely replaced it
  • Imatinib (Gleevec) – A targeted therapy for metastatic melanoma with C-KIT gene mutations
  • Imiquimod (Aldara, Zyclara) – A topical immunotherapy cream applied directly to skin lesions
  • Lifileucel (Amtagvi) – A tumor infiltrating lymphocyte therapy for melanoma
  • Relatlimab – An immunotherapy drug that can be combined with nivolumab (Opdualag) to enhance treatment effectiveness

Ongoing Clinical Trials on Metastatic malignant melanoma

  • Study on Detecting Untreated Brain Metastases in Lung, Breast, and Melanoma Cancer Patients Using Fluorodopa (18F)

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France
  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated drugs:
    Greece Hungary Romania

References

https://www.ncbi.nlm.nih.gov/books/NBK470358/

https://www.webmd.com/melanoma-skin-cancer/metastatic-melanoma

https://www.macmillan.org.uk/cancer-information-and-support/melanoma/advanced-melanoma

https://my.clevelandclinic.org/health/diseases/14391-melanoma

https://myhealth.alberta.ca/Health/Pages/conditions.aspx?hwid=hw206142

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC2737459/

https://cancer.ca/en/cancer-information/cancer-types/melanoma-skin/treatment/metastatic

https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq

https://www.mdanderson.org/cancer-types/melanoma/melanoma-treatment.html

https://emedicine.medscape.com/article/280245-treatment

https://www.mskcc.org/cancer-care/types/melanoma/treatment/immunotherapy-melanoma

https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/coping-advanced-melanoma

https://www.curemelanoma.org/patient-eng/ten-tips-for-people-just-diagnosed-with-melanoma/practicing-self-care

https://www.webmd.com/melanoma-skin-cancer/skin-stage-iv-self-care

https://www.cancer.org/cancer/types/melanoma-skin-cancer/after-treatment/follow-up.html

https://www.curemelanoma.org/blog/what-you-control-your-microbiome-diet-stress-and-melanoma

FAQ

What does it mean when melanoma becomes metastatic?

Metastatic melanoma means the cancer has spread beyond its original location in the skin to other parts of the body. It most commonly spreads to nearby skin and lymph nodes first, then potentially to distant organs like the lungs, liver, bones, or brain. This is also called stage IV melanoma or advanced melanoma.

Can metastatic melanoma be cured?

While metastatic melanoma can be very challenging to cure completely, newer treatments including immunotherapy and targeted therapy have significantly improved outcomes. Some patients achieve long-lasting responses or even complete remission. High-dose interleukin-2 immunotherapy has produced durable responses in a small percentage of patients, meaning they remain cancer-free for many years. Treatment success depends on multiple factors including where the cancer has spread and how well it responds to therapy.

How quickly does metastatic melanoma spread?

Melanoma is known for growing and spreading quickly compared to other skin cancers. However, the speed varies considerably from person to person. The risk of metastasis is directly related to characteristics of the original tumor, particularly how deeply it invaded the skin and whether it showed ulceration. Some melanomas may spread within months while others progress more slowly over longer periods.

What are the treatment options for metastatic melanoma?

Treatment options have expanded greatly in recent years and include immunotherapy drugs like nivolumab and pembrolizumab, targeted therapies such as BRAF and MEK inhibitors for tumors with specific mutations, surgery in select cases, radiation therapy, and sometimes chemotherapy. Many patients receive combination treatments. Clinical trials offer access to even newer therapies under development.

Does where the melanoma spreads affect survival?

Yes, the location of metastases significantly impacts prognosis. Patients whose melanoma spreads to skin, subcutaneous tissue, nearby lymph nodes, or the gastrointestinal tract typically have better outcomes with a median survival of about 12.5 months. Those with lung-only metastases have intermediate outcomes around 8 months, while spread to the liver, brain, or bones indicates more aggressive disease with a median survival of approximately 4.4 months. However, newer treatments may improve these statistics.

🎯 Key takeaways

  • Metastatic melanoma has spread from its original skin location to other body parts, most commonly affecting nearby skin, lymph nodes, lungs, liver, bones, or brain
  • Where the cancer spreads dramatically affects survival outlook, with skin and lymph node involvement having better prognosis than liver, brain, or bone metastases
  • Treatment options have revolutionized in the past decade, with immunotherapy and targeted therapy now offering hope where previously few options existed
  • The depth of the original melanoma and whether it showed ulceration directly influence the risk of metastasis
  • Clinical trials represent an important option for metastatic melanoma patients, potentially providing access to cutting-edge therapies not yet widely available
  • Living with metastatic melanoma affects every aspect of daily life, from physical abilities to emotional well-being, work, relationships, and leisure activities
  • Family support is crucial—loved ones can help with practical tasks, accompany patients to appointments, research treatment options, and provide emotional comfort
  • Self-care remains essential during treatment, including managing energy carefully, maintaining activities that bring joy, and seeking emotional support through counseling or support groups